The official journal of the Ophthalmological Society of South Africa
Download full journal PDF
Management of the painful blind eye: An update
Author: L Branders, A Asvat
Source: SA Ophthalmology Journal 18(4), p8-12
The blind painful eye (BPE) can be defined as an end-stage ocular condition with no chance of visual restoration accompanied by ocular pain. The focus of care shifts to addressing quality of life, and counselling patients about the finality of the loss of vision.
Download PDF
Outcomes of uveitic cataract surgery in a cohort of South African children
Author: C Kennedy, J Steffen, C Tinley
Source: SA Ophthalmology Journal 18(4), p16-19
Cataract formation is a common and potentially blinding complication of paediatric uveitis. Surgical management approach remains a point of controversy. The purpose of this study was to determine the peri- and postoperative outcomes of uveitic cataract surgery in a cohort of South African children.
Download PDF
Outcomes of uveitic cataract surgery in a cohort of South African children
Author: T Mofokeng
Source: SA Ophthalmology Journal 18(4), p21-23
The purpose of this study is to determine the spectrum of histopathological findings conjunctival lesions at St John Eye Hospital
Download PDF
Unadjusted versus Adjusted Intraocular Pressure for Central Corneal Thickness in Healthy Congolese Subjects
Author: J Kelekele, Jean-Claude Mwanza
Source: SA Ophthalmology Journal 18(4), p25-30
This study compared uncorrected and corrected IOP using existing reference CCT values and Congolese reference CCT value and to assess the relationship of CCT with uncorrected and corrected IOP.
Download PDF
Treatment outcomes with micropulse transscleral cyclophotocoagulation in refractory and non-refractory glaucoma in a South African context: a retrospective analysis of 163 eyes
Author: N Narainswami, C Kruse
Source: SA Ophthalmology Journal 18(4), p32-36
Micropulse trans-scleral cyclophotocoagulation (M-TSCPC) is being recognised as a valid therapeutic option in glaucomatous eyes with good visual potential. The aims of this study were to evaluate the efficacy and safety of this novel therapeutic option in a wide range of glaucomatous eyes.
